Sanjay Ramakrishnan
Clinical Researcher
Sanjay Ramakrishnan is a clinical research fellow researching exacerbations of obstructive lung disease at the Nuffield Department of Medicine. He is also completing a PhD via Edith Cowan University in Australia.
Recent publications
-
Antibiotics for asthma attacks: masking uncertainty.
Journal article
Ramakrishnan S. and Couillard S., (2021), The European respiratory journal, 58
-
Inhaled budesonide for early treatment of COVID-19 - Authors' reply.
Journal article
Ramakrishnan S. and Bafadhel M., (2021), The Lancet. Respiratory medicine
-
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
Journal article
Crossingham I. et al, (2021), Cochrane Database of Systematic Reviews
-
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Journal article
Yu L-M. et al, (2021)
-
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Journal article
Ramakrishnan S. et al, (2021), The Lancet Respiratory Medicine